CHMP2B
Pathway Diagram
Mermaid diagram (expand to render)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CHMP2B</th>
</tr>
<tr> [@frontotemporal2018]
<td class="label">Gene</td> [@lessons2021]
<td>[CHMP2B](/genes/chmp2b)</td> [@enhanced2022]
</tr> [@uniprot]
<tr> [@page2026]
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9UQN3" target="_blank">Q9UQN3</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td>N/A</td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>24 kDa</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>[Endosomes and endolysosomal membranes](/mechanisms/lysosome-dysfunction)</td>
</tr>
<tr>
<td class="label">Family</td>
<td>[ESCRT-III complex](/entities/autophagy) family</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Frontotemporal Dementia](/diseases/ftd), <a href="/diseases/als">ALS<sup><a href="#references" class="ref-link" data-ref-number="5" data-ref-text="Frontotemporal Dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by [TMEM106B](/proteins/tmem106b-protein) knockdown. Brain, 2018. DOI" data-ref-title="DOI" data-ref-authors="" data-ref-journal="" data-ref-year="2018" data-ref-url="https://doi.org/10.1093/brain/awy284" title="Frontotemporal Dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by [TMEM106B](/proteins/tmem106b-protein) knockdown. Brain, 2018. DOI">5</a></sup></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-8986b8af" style="color:#ce93d8" title="Score: 0.43">Lysosomal Membrane Repair Enhancement...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">188 edges</a></td>
</tr>
</table>
CHMP2B
Introduction
Chmp2B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
CHMP2B is a protein encoded by the [CHMP2B](/proteins/chmp2b-protein) gene. It belongs to the [ESCRT-III complex](/entities/autophagy) family family and has a molecular weight of approximately 24 kDa[@mutations2005]. This protein is localized to [Endosomes and endolysosomal membranes](/mechanisms/lysosome-dysfunction) and plays a significant role in the pathogenesis of [Frontotemporal Dementia](/diseases/frontotemporal-dementia), [ALS](/diseases/als).
Structure
CHMP2B has been characterized structurally through X-ray crystallography and cryo-EM. Available PDB structures include: No structures deposited.
The protein's three-dimensional structure can also be explored via the [AlphaFold Protein Structure Database](https://alphafold.ebi.ac.uk/entry/Q9UQN3).
Normal Function
Under physiological conditions, CHMP2B performs essential functions in the nervous system. It is primarily found in [Endosomes and endolysosomal membranes](/mechanisms/lysosome-dysfunction) and contributes to normal cellular homeostasis, signaling, and neuronal function.
ESCRT Complex Function
CHMP2B is a member of the ESCRT-III (Endosomal Sorting Complex Required for Transport III) machinery, which plays critical roles in:
- Multivesicular body (MVB) formation: Sorting ubiquitinated cargo into intralumenal vesicles
- Endosomal trafficking: Regulating receptor degradation and recycling
- Lysosomal delivery: Directing cargo to lysosomes for degradation
- Autophagosome-lysosome fusion: Supporting [autophagy](/entities/autophagy) completion
- Cytokinesis: Facilitating membrane fission during cell division
The ESCRT-III complex consists of multiple charged multivesicular body proteins (CHMP2A, CHMP2B, CHMP4A/B/C, CHMP6, CHMP7) that polymerize on endosomal membranes to drive vesicle budding.
Pathogenic Mutations
Several pathogenic mutations in CHMP2B have been linked to familial frontotemporal dementia (FTD) and ALS:
- p.Arg69His: First identified in Danish FTD families, causes endolysosomal trafficking defects
- p.Ile94Thr: Impairs ESCRT-III polymerization and function
- p.Gln206X: Truncation mutation leading to loss of function
- p.Asp187Val: Disrupts protein-protein interactions
These mutations lead to
endolysosomal dysfunction, characterized by:
- Accumulation of enlarged endosomes
- Impaired autophagic flux
- Reduced degradation of neurodegenerative disease proteins ([tau](/proteins/tau), [α-synuclein](/proteins/alpha-synuclein), TDP-43)
- Neuronal vulnerability and death
Therapeutic Implications
Given CHMP2B's central role in endolysosomal trafficking, therapeutic strategies include:
Gene therapy approaches: Delivering wild-type CHMP2B to restore function
Small molecule modulators: Targeting ESCRT assembly or function
TMEM106B modulation: As CHMP2B and TMEM106B interact genetically
Autophagy enhancement: Bypassing defective ESCRT-mediated autophagy
Anti-sense oligonucleotides: Reducing expression of mutant alleles
Interacting Proteins
CHMP2B interacts with several key proteins in its function:
- VPS4: AAA ATPase required for ESCRT-III disassembly
- CHMP2A: Paralog that compensates for CHMP2B function
- CHMP4B: Core ESCRT-III subunit
- TMEM106B: Lysosomal transmembrane protein modified by FTD-risk variants
- p62/SQSTM1: Autophagy receptor linking ubiquitinated cargo to autophagosomes
- OPTN: Optineurin, another FTD/ALS-associated autophagy receptor
Role in Disease
CHMP2B is implicated in the following neurodegenerative conditions:
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- [ALS](/diseases/als)
Misfolding, aggregation, or dysfunction of CHMP2B contributes to neuronal damage through various mechanisms including [proteotoxic stress](/mechanisms/proteostasis-failure), disrupted cellular signaling, and [neuroinflammation](/mechanisms/neuroinflammation).
Therapeutic Targeting
CHMP2B represents an important therapeutic target. Multiple drug development programs are exploring strategies to modulate its function, reduce toxic forms, or enhance clearance mechanisms.
External Links
- UniProt: [https://www.uniprot.org/uniprot/Q9UQN3](https://www.uniprot.org/uniprot/Q9UQN3)
- AlphaFold: [CHMP2B](https://alphafold.ebi.ac.uk/entry/Q9UQN3)
- PDB: No structures deposited
See Also
- [Proteins Index](/proteins)
- [Genes Index](/genes)
- [Diseases Index](/diseases)
- [Mechanisms Index](/mechanisms)
Brain Atlas Resources
- Allen Human Brain Atlas: [CHMP2B expression search](https://human.brain-map.org/microarray/search/show?search_term=CHMP2B)
- Allen Mouse Brain Atlas: [CHMP2B search](https://mouse.brain-map.org/search/index.html?query=CHMP2B)
- Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
- BrainSpan Developmental Transcriptome: [CHMP2B developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=CHMP2B)
Background
The study of Chmp2B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in Frontotemporal Dementia (2005)](https://doi.org/10.1038/ng1609)
[Unknown, The role of CHMP2B in Frontotemporal Dementia (2009)](https://doi.org/10.1042/BST0370208)
[Unknown, Frontotemporal Dementia caused by CHMP2B mutations (2011)](https://doi.org/10.2174/156720511795563764)
[Unknown, Frontotemporal Dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology (2015)](https://doi.org/10.1007/s00401-015-1475-3)
[Unknown, Frontotemporal Dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by [TMEM106B](/proteins/tmem106b-protein) knockdown (2018)](https://doi.org/10.1093/brain/awy284)
[Unknown, Lessons learned from CHMP2B, implications for Frontotemporal Dementia and amyotrophic lateral sclerosis (2021)](https://doi.org/10.1016/j.nbd.2020.105144)
[Unknown, The enhanced association between mutant CHMP2B and spastin is a novel pathological link between Frontotemporal Dementia and hereditary spastic paraplegia (2022)](https://doi.org/10.1186/s40478-022-01476-8)
UniProt:, Q9UQN3 (n.d.)
Unknown, Page auto-generated from NeuroWiki protein database. Last updated: 2026-02-26. (2026)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Lysosomal Membrane Repair Enhancement](/hypothesis/h-8986b8af) — <span style="color:#ffd54f;font-weight:600">0.43</span> · Target: CHMP2B
Pathway Diagram
The following diagram shows the key molecular relationships involving CHMP2B discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)